Skip to main content
. Author manuscript; available in PMC: 2024 May 6.
Published in final edited form as: Arch Neurol. 2008 Jan;65(1):89–93. doi: 10.1001/archneurol.2007.29

eTable 2.

Risk of Dementia and Subtypes by Sex

Hazard Ratio (95% Confidence Interval)

Men Women


Dementia Status Model 1a Model 2b Model 1a Model 2b

Total Dementia (n=2547 [1503 Women, 1044 Men])
Diabetes only 1.52 (0.95–2.42) 1.43 (0.89–2.30) 1.34 (0.84–2.16) 1.43 (0.88–2.32)
APOE ε4 only 1.55 (1.06–2.26) 1.59 (1.08–2.34) 2.47 (1.86–3.26) 2.47 (1.86–3.29)
Bothc 3.05 (1.62–5.75) 2.38 (1.24–4.54) 3.88 (1.87–8.05) 4.72 (2.23–10.0)

AD (n=2343 [1394 Women, 949 Men]) d
Diabetes only 1.85 (0.88–3.91) 1.87 (0.88–4.00) 1.31 (0.67–2.55) 1.53 (0.77–3.04)
APOE ε4 only 2.32 (1.33–4.04) 2.57 (1.44–4.56) 2.82 (1.95–4.09) 2.78 (1.91–4.04)
Bothe 4.90 (2.13–11.27) 4.78 (2.02–11.30) 4.94 (1.95–12.49) 5.95 (2.29–15.5)

Mixed AD (n=2268 [1332 Women, 936 Men]) d
Diabetes only 1.53 (0.70–3.34) 1.37 (0.62–3.06) 2.10 (0.96–4.56) 2.06 (0.91–4.68)
APOE ε4 only 1.30 (0.65–2.59) 1.25 (0.63–2.52) 3.56 (2.14–5.95) 3.55 (2.10–5.99)
Bothc 3.52 (1.06–11.72) 2.19 (0.62–7.64) 7.80 (2.30–26.42) 10.37 (2.94–35.53)

VaD (n=2194 [1283 Women, 911 Men]) f
Diabetes only 0.89 (0.26–3.00) 0.80 (0.23–2.75) 1.02 (0.23–4.42) 0.93 (0.20–4.42)
APOE ε4 only 1.06 (0.42–2.65) 1.04 (0.41–2.63) 0.80 (0.27–2.35) 0.79 (0.25–2.37)
Bothe 1.28 (0.17–9.71) 0.55 (0.07–4.45) NE NE

Abbreviations: AD, Alzheimer disease; APOE ε4, ε4 allele of the apolipoprotein E genotype; NE, not estimable due to small sample size; VaD, vascular dementia.

a

Adjusted for age and years of education.

b

Adjusted for age, years of education, hypertension, total cholesterol, smoking, alcohol, race, body mass index, depression status, ankle-brachial index, and stroke.

c

Cross-product between diabetes/APOE ε4 subgroups and sex, P>.1. The analysis was adjusted as in model 1.

d

Excluded participants with VaD and other types of dementia.

e

Cross-product between diabetes/APOE ε4 subgroups and sex, P>.2. The analysis was adjusted as in model 1.

f

Excluded participants with AD and other types of dementia.